Biovie BIVI Peer Comparison

NASDAQ BIVI
$1.94 -0.03 (-1.62%)
As of: Sep 10, 2026 · 11:59 AM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

The table below compares all 300 Biotechnology companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 207.26 Bn 23.71 5.44 193.27 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 179.66 Bn -62.06 5.90 176.48 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 131.52 Bn 29.86 10.45 123.67 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 81.77 Bn 18.89 5.26 73.78 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 61.15 Bn 35.65 11.70 55.97 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 53.55 Bn -17.00 24.04 48.41 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 33.38 Bn 43.09 6.95 30.07 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 31.68 Bn 37.96 3.16 30.40 Bn
9 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 29.12 Bn -19.62 2,665.55 29.12 Bn
10 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.69 Bn -31.63 24.34 26.53 Bn
11 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 23.38 Bn -13.72 7.56 9.73 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 15.78 Bn 18.20 11.13 14.83 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.30 Bn -47.95 11.91 14.46 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.47 Bn -20.92 20.29 13.75 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.27 Bn — — 12.58 Bn
16 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.65 Bn 30.58 7.60 12.42 Bn
17 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.56 Bn 172.05 3.69 11.68 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 11.80 Bn -43.37 17.63 10.20 Bn
19 AAVXF Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
21 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 9.88 Bn -25.89 — 9.12 Bn
22 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.54 Bn 86.36 33.82 9.54 Bn
23 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.15 Bn -43.10 10.46 7.09 Bn
24 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.62 Bn -8.15 — 8.62 Bn
25 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.14 Bn -8.20 49.09 7.78 Bn
26 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.80 Bn 17.66 9.76 7.12 Bn
27 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.76 Bn -14.41 — 7.76 Bn
28 GIFLF Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
29 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.42 Bn -41.47 — 7.42 Bn
30 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.32 Bn -18.14 — 7.32 Bn
31 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.01 Bn -33.36 29.23 6.68 Bn
32 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.35 Bn -708.81 4,560.40 6.35 Bn
33 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.33 Bn -28.23 1,015.97 6.33 Bn
34 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.22 Bn -7.23 10.06 5.78 Bn
35 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.92 Bn 73.44 7.05 5.40 Bn
36 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.90 Bn -16.27 — 5.90 Bn
37 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.79 Bn 29.38 19.94 4.44 Bn
38 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.73 Bn — — 4.00 Bn
39 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.69 Bn -15.40 — 5.69 Bn
40 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.69 Bn -32.32 1,133.29 5.51 Bn
41 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.58 Bn 14.59 5.53 3.35 Bn
42 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.03 Bn -17.53 — 5.03 Bn
43 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.73 Bn -21.62 — 4.73 Bn
44 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 4.00 Bn — — 3.60 Bn
45 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.00 Bn -7.82 1,109.13 4.00 Bn
46 TLPPF Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
47 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.81 Bn -13.32 367.87 3.81 Bn
48 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.76 Bn -7.02 — 3.76 Bn
49 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.59 Bn -29.50 — 3.59 Bn
50 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.51 Bn -15.96 15.01 2.68 Bn
51 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.51 Bn -34.31 65.26 2.50 Bn
52 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.44 Bn -7.48 29.42 2.74 Bn
53 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.31 Bn -20.13 50.08 3.31 Bn
54 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.06 Bn 107.48 6.60 2.82 Bn
55 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.01 Bn -5.82 — 3.01 Bn
56 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.99 Bn -9.73 18,923.00 2.99 Bn
57 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.95 Bn -28.29 — 2.95 Bn
58 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.90 Bn -10.72 593.06 2.38 Bn
59 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.87 Bn -14.27 — 2.87 Bn
60 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.84 Bn -8.32 77.26 2.40 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.74 Bn -14.58 6.10 2.04 Bn
62 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.58 Bn -79.60 — 2.58 Bn
63 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.46 Bn -8.13 47.26 2.46 Bn
64 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.42 Bn -6.04 — 2.42 Bn
65 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.39 Bn -20.08 43.70 1.70 Bn
66 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
67 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.33 Bn -5.82 32.72 2.33 Bn
68 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.29 Bn -11.52 — 1.92 Bn
69 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.17 Bn -34.83 11.49 2.06 Bn
70 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.13 Bn 12.82 4.16 2.00 Bn
71 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.10 Bn 0.17 0.33 0.59 Bn
72 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn -5.44 3.91 1.74 Bn
73 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -15.14 103.81 2.08 Bn
74 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -8.49 — 2.05 Bn
75 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.99 Bn -4.84 20.25 1.99 Bn
76 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn -4.73 1,968.16 1.97 Bn
77 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn -13.06 52.75 1.69 Bn
78 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -3.29 — 1.67 Bn
79 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -9.29 69.95 1.64 Bn
80 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn -4.86 — 1.92 Bn
81 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.83 Bn -11.18 17.39 1.45 Bn
82 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.78 Bn -7.09 5.88 1.78 Bn
83 GLPGF Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
84 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -12.92 1,325.96 1.72 Bn
85 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -123.42 17.43 1.72 Bn
86 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -94.84 3.98 0.84 Bn
87 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -3.28 31.01 1.15 Bn
88 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -9.27 6.66 1.13 Bn
89 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn -6.38 — 1.14 Bn
90 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.66 Bn -26.65 — 1.30 Bn
91 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -10.37 525.54 1.60 Bn
92 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
93 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -65.78 7.89 1.28 Bn
94 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -8.47 — 1.57 Bn
95 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -187.32 911.17 1.57 Bn
96 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.51 Bn -6.11 3.66 0.79 Bn
97 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.50 Bn -10.09 — 1.50 Bn
98 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -9.11 20.12 1.21 Bn
99 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.48 Bn -13.97 74.07 1.48 Bn
100 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -3.16 2.04 1.17 Bn
101 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.35 50.09 0.81 Bn
102 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.40 Bn -8.53 — 1.40 Bn
103 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn -16.49 — 1.38 Bn
104 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn -9.68 — 1.35 Bn
105 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn 78.50 34.87 1.34 Bn
106 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -8.46 — 1.33 Bn
107 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -4.46 — 1.33 Bn
108 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.32 Bn -10.89 844.86 1.12 Bn
109 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.28 Bn -6.29 — 1.28 Bn
110 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.25 Bn -5.15 149.90 0.75 Bn
111 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -1.32 — 1.22 Bn
112 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.20 Bn -25.03 — 0.98 Bn
113 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.18 Bn -27.05 3.00 1.07 Bn
114 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -11.40 48.72 1.17 Bn
115 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.16 Bn -7.59 — 1.16 Bn
116 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.08 Bn -18.82 — 1.08 Bn
117 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 6.64 5.56 0.92 Bn
118 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -3.71 — 0.45 Bn
119 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -118.02 — 0.97 Bn
120 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.95 Bn -4.71 14.57 0.58 Bn
121 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -68.13 — 0.89 Bn
122 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.92 Bn -13.69 3.78 0.62 Bn
123 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn -16.34 2.02 0.63 Bn
124 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.81 8.44 0.49 Bn
125 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn 2.69 3.13 0.77 Bn
126 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn -4.12 — 0.84 Bn
127 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -15.00 809.82 0.81 Bn
128 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn -7.73 — 0.78 Bn
129 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn -9.73 94.21 0.77 Bn
130 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.75 Bn -9.86 40.85 0.42 Bn
131 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -119.63 2.23 0.58 Bn
132 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.71 Bn -6.10 — 0.71 Bn
133 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.66 Bn -6.04 — 0.59 Bn
134 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 2.95 1.68 0.57 Bn
135 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -16.12 1,018.85 0.55 Bn
136 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.20 — 0.61 Bn
137 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -12.38 — 0.60 Bn
138 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -3.65 573.77 0.42 Bn
139 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -338,715.34 — 0.59 Bn
140 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 465.89 7.74 0.26 Bn
141 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.70 3.39 0.42 Bn
142 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn 60.27 1.77 -0.01 Bn
143 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -9.27 — 0.56 Bn
144 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn -6.30 — 0.54 Bn
145 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.52 Bn -11.65 13.41 0.46 Bn
146 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -4.38 — 0.50 Bn
147 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -7.35 22.09 0.21 Bn
148 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn -10.27 78.36 0.26 Bn
149 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn -10.82 8.71 0.19 Bn
150 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -19.67 — 0.45 Bn
151 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.52 2.01 0.37 Bn
152 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 14.88 2.41 0.39 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -7.53 — 0.46 Bn
154 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -2.24 — 0.22 Bn
155 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -15.28 — 0.45 Bn
156 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -5.43 — 0.44 Bn
157 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.30 12.42 0.18 Bn
158 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.08 — 0.42 Bn
159 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.22 13.68 0.21 Bn
160 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.18 39.60 0.20 Bn
161 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -2.24 — 0.24 Bn
162 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.81 — 0.39 Bn
163 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.15 37.67 0.39 Bn
164 HMDCF HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
165 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -5.95 5.76 0.19 Bn
166 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.36 Bn -1.17 129.71 0.18 Bn
167 DMAC DiaMedica Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -10.36 — 0.34 Bn
168 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -2.85 — 0.34 Bn
169 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -4.17 — 0.33 Bn
170 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.47 — 0.32 Bn
171 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -4.86 8.69 0.25 Bn
172 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.82 — 0.32 Bn
173 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn -1.95 98.84 0.31 Bn
174 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn -2.62 3.31 0.13 Bn
175 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 3.10 2.14 0.28 Bn
176 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -15.67 — 0.28 Bn
177 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.67 59.20 0.28 Bn
178 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -5.12 12.51 0.28 Bn
179 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -4.02 — 0.28 Bn
180 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.42 4.43 0.27 Bn
181 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.23 — 0.26 Bn
182 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -9.17 — 0.26 Bn
183 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.61 — 0.26 Bn
184 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -3.03 4.54 0.10 Bn
185 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 63.95 — 0.15 Bn
186 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.13 — 0.25 Bn
187 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -15.76 1.52 0.14 Bn
188 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -17.30 — 0.12 Bn
189 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -4.85 57.50 0.24 Bn
190 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.57 3.12 0.15 Bn
191 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.78 20.02 0.23 Bn
192 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.76 95.93 0.11 Bn
193 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.57 16.29 0.05 Bn
194 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -9.93 — 0.22 Bn
195 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.44 6.69 -0.04 Bn
196 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.11 — 0.22 Bn
197 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 10.16 2.67 0.17 Bn
198 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.31 — 0.21 Bn
199 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.94 — 0.21 Bn
200 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -3.15 14.98 0.17 Bn
201 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -4.17 9.55 0.07 Bn
202 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.54 4.00 0.10 Bn
203 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.93 — 0.20 Bn
204 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 1.14 — 0.19 Bn
205 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -13.14 32.66 0.19 Bn
206 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -3.13 — 0.17 Bn
207 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.47 — 0.19 Bn
208 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.81 8.14 0.17 Bn
209 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.21 2.37 -0.04 Bn
210 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.36 — 0.18 Bn
211 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.52 2.70 0.04 Bn
212 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.06 60.09 0.17 Bn
213 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -2.69 — -0.01 Bn
214 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -10.75 — 0.15 Bn
215 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.42 190.84 0.16 Bn
216 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -5.00 13.09 0.12 Bn
217 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -4.72 31.82 0.16 Bn
218 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -116.03 — 0.15 Bn
219 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.91 — 0.15 Bn
220 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.02 Bn
221 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -5.12 — 0.14 Bn
222 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -9.65 — 0.13 Bn
223 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,741.29 -0.05 Bn
224 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.78 — 0.13 Bn
225 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.30 — 0.13 Bn
226 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -6.12 37.53 0.10 Bn
227 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -3.90 1,285.14 0.13 Bn
228 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.72 128.60 0.13 Bn
229 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.95 — 0.07 Bn
230 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -1.80 41.95 0.12 Bn
231 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.37 — 0.11 Bn
232 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -6.55 — 0.11 Bn
233 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -2.33 — 0.00 Bn
234 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.38 — 0.11 Bn
235 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -4.78 13.31 0.06 Bn
236 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn — — -0.06 Bn
237 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.91 — 0.09 Bn
238 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 2.13 150.51 0.10 Bn
239 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -2.09 60.89 0.10 Bn
240 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.04 — 0.09 Bn
241 TLPH Talphera, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -6.39 90,254.65 0.09 Bn
242 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.91 — 0.09 Bn
243 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.45 — 0.08 Bn
244 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -118.64 — 0.09 Bn
245 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 2.71 — 0.08 Bn
246 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.13 — 0.08 Bn
247 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 9.91 1.20 -0.11 Bn
248 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.08 Bn
249 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.69 — 0.08 Bn
250 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -2.97 — 0.05 Bn
251 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.81 128.54 0.08 Bn
252 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 — 0.07 Bn
253 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -3.99 — 0.07 Bn
254 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.48 — 0.07 Bn
255 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 11.51 1.42 0.02 Bn
256 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.60 — 0.07 Bn
257 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.81 — 0.07 Bn
258 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -6.91 0.41 0.02 Bn
259 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -3.16 2.96 -0.06 Bn
260 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.78 14.70 0.02 Bn
261 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.07 — 0.05 Bn
262 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -2.83 1,519.97 0.05 Bn
263 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.27 — 0.05 Bn
264 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.49 — 0.05 Bn
265 BDRX Biodexa Pharmaceuticals Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -6.38 — 0.04 Bn
266 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.60 26.16 0.05 Bn
267 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.40 5.09 0.05 Bn
268 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.41 2.27 0.05 Bn
269 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.51 3.66 0.05 Bn
270 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -4.41 — 0.04 Bn
271 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
272 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.98 — 0.04 Bn
273 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.67 294.15 -0.01 Bn
274 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 3.62 1.17 0.04 Bn
275 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.44 312.58 0.02 Bn
276 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.03 — 0.02 Bn
277 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.02 78.59 0.04 Bn
278 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.63 — 0.04 Bn
279 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.66 — 0.03 Bn
280 ALP Alpha Compute Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.02 0.19 0.03 Bn
281 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.75 — 0.03 Bn
282 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.72 4.79 0.03 Bn
283 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.82 — 0.04 Bn
284 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.09 0.93 0.02 Bn
285 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.16 4.24 0.03 Bn
286 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
287 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -6.19 0.38 0.03 Bn
288 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.25 — 0.03 Bn
289 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.32 37.63 0.03 Bn
290 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -12.26 93.50 0.03 Bn
291 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -23.02 — 0.03 Bn
292 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.44 — 0.03 Bn
293 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.63 — 0.03 Bn
294 YDESW YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
295 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.30 869.19 0.02 Bn
296 RDPTF Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.28 97.58 0.02 Bn
297 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.45 — 0.02 Bn
298 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.70 — 0.02 Bn
299 GRDX GridAI Technologies Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.12 261.63 0.02 Bn
300 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.10 — 0.02 Bn